A monocentric Phase I pivotal pharmacology study for the determination of the local and systemic exposure of locally applied Minocycline in periodontal pockets via a newly developed pharmaceutical formulation for the treatment of patients with recurrent or persistent periodontitis

This study is about finding a better way to treat a common gum problem called periodontitis. Periodontitis happens when harmful bacteria build up in your mouth, causing your gums to become inflamed, bleed, and pull away from your teeth. If not treated, it can damage the bone supporting your teeth and eventually lead to tooth loss. Even after initial treatments, some people still have ongoing gum problems.

Researchers are testing a new type of treatment – a special gel containing a medicine called minocycline. Minocycline is an antibiotic, which means it helps fight off bacterial infections. The idea is to apply this gel directly into the deep pockets that form around your teeth due to gum disease. By putting the medicine exactly where it's needed, the hope is to clear up the infection more effectively.

The main goal of this particular study is to understand how the new minocycline gel behaves in your body. They want to see how much of the medicine stays in the gum pockets and how much might get absorbed into your overall system. This helps them work out the best dose and make sure the treatment is safe and reaches the right places to do its job.